Voglibose 0.3 mg tablets are used to help control blood glucose levels in people with type 2 diabetes mellitus, particularly the rise in blood glucose after meals. They belong to a class of medicines called alpha-glucosidase inhibitors, which slow the digestion and absorption of carbohydrates in the intestine. Voglibose is used alongside dietary measures and other diabetes treatments when prescribed.
Voglibose 0.3 mg contains voglibose, an oral antidiabetic medicine that acts mainly in the small intestine. It belongs to the alpha-glucosidase inhibitor class.
The medicine helps reduce the rise in blood glucose after meals by slowing the breakdown of complex carbohydrates into absorbable sugars. It may be prescribed as part of a treatment plan that includes dietary changes and other glucose-lowering medicines.
Voglibose 0.3 mg may be prescribed to:
Help control blood glucose levels in people with type 2 diabetes mellitus.
Reduce increases in blood glucose after meals.
Support blood glucose management alongside dietary measures and other prescribed diabetes medicines when needed.
The appropriate treatment and dose should be determined by a healthcare professional based on blood glucose levels, medical history and other medicines being used.
Voglibose inhibits alpha-glucosidase enzymes in the small intestine, which normally break down carbohydrates into simpler sugars that can be absorbed into the bloodstream.
By slowing carbohydrate digestion, voglibose delays glucose absorption and helps reduce the rise in blood glucose after meals. It acts mainly in the intestine and does not directly stimulate insulin release.
Take Voglibose exactly as prescribed by your healthcare professional.
Timing: It is generally taken immediately before or with meals, according to the product instructions and prescription.
Frequency: It may be prescribed with main meals. The exact dose and frequency depend on the treatment plan.
Administration: Take the tablet orally with water, following the instructions supplied with your product.
Missed dose: Follow the patient information leaflet or ask your pharmacist for advice. Do not take a double dose to make up for a missed dose.
Treatment duration: Do not stop treatment or change the dose without consulting your healthcare professional.
Follow your prescribed schedule carefully because voglibose is intended to help control the rise in blood glucose associated with meals.
Tell your doctor or pharmacist about your medical history and all medicines, supplements, vitamins and herbal products you use before starting voglibose.
Use caution and seek medical advice if you have any of the following:
Digestive disorders: Voglibose may be unsuitable for people with intestinal obstruction, inflammatory bowel disease or conditions that may worsen with increased intestinal gas.
Liver disease: Liver problems may require additional assessment and monitoring.
Diabetes-related emergencies: Voglibose is not intended to treat diabetic ketoacidosis or diabetic pre-coma.
Previous allergic reactions: Tell your healthcare professional if you have had an allergic reaction to voglibose or any of its ingredients.
Severe illness or surgery: Severe infection, serious injury or the period around surgery may affect blood glucose control and require a review of diabetes treatment.
Important medicine interactions: When voglibose is combined with insulin, sulphonylureas or other glucose-lowering medicines, the risk of hypoglycaemia may increase. Certain medicines that affect blood glucose, including some corticosteroids, thyroid hormones and other medicines that alter glucose control, may also require consideration.
Check possible interactions with your doctor or pharmacist before starting voglibose or changing any existing treatment.
The safety of voglibose during pregnancy has not been established in adequate studies. It should generally be used during pregnancy only when a healthcare professional determines that the expected benefits outweigh potential risks.
Voglibose is generally not recommended during breastfeeding because of limited safety information. Speak with your doctor or pharmacist about appropriate diabetes treatment if you are pregnant, planning a pregnancy or breastfeeding.
Like all medicines, Voglibose can cause side effects, although not everyone experiences them.
Possible side effects include:
Flatulence (increased gas).
Abdominal bloating or discomfort.
Loose stools or diarrhoea.
Abdominal pain.
Nausea or constipation.
Seek prompt medical attention for severe abdominal pain, persistent vomiting, or marked abdominal swelling with constipation, as these may indicate a serious intestinal problem. Yellowing of the skin or eyes, or signs of a serious allergic reaction such as facial swelling or difficulty breathing, also require urgent medical attention. Low blood glucose may occur, particularly when voglibose is combined with other diabetes medicines.
This is not a complete list of side effects or warnings. Please refer to the product packaging and patient information leaflet supplied with your medicine for complete information and speak with your doctor or pharmacist if you have concerns.
Store Voglibose according to the instructions shown on the original product packaging.
Keep the medicine in its original packaging where appropriate.
Protect it from moisture and store it away from excessive heat, following the product leaflet.
Keep out of reach of children.
Do not use the medicine after its expiry date.
Storage requirements may vary by manufacturer and product presentation. Follow the instructions supplied with your specific product.
Voglibose 0.3 mg is used to help control blood glucose levels after meals in people with type 2 diabetes. It is generally used alongside dietary measures and may be combined with other diabetes medicines.
Voglibose slows the action of enzymes in the small intestine that break down carbohydrates. This delays glucose absorption and reduces the rise in blood glucose after eating.
Voglibose is generally taken immediately before or with a meal, according to the prescribed instructions. Follow the timing specified by your healthcare professional and the product leaflet.
Voglibose alone does not usually cause low blood glucose because it does not directly stimulate insulin release. The risk increases when it is taken with insulin or certain other diabetes medicines.
Follow the missed-dose instructions in your patient information leaflet or ask your pharmacist. Do not take a double dose to make up for a missed dose.
Yes, a healthcare professional may prescribe voglibose alongside other glucose-lowering medicines. Combining treatments can increase the risk of hypoglycaemia, so appropriate monitoring and professional guidance are important.
Its safety during pregnancy and breastfeeding has not been established sufficiently, and use is generally avoided or restricted unless a healthcare professional considers it necessary. Seek medical advice before using voglibose in either situation.
